Glycanreactive antibodies isolated from human HIV1 vaccine trial participants show broad pathogen crossreactivity
| dc.article.end-page | 30 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1128/JVI.01256 | en |
| dc.contributor.author | Parker Jamieson | en |
| dc.contributor.author | X Shen | en |
| dc.contributor.author | A Abu-Shmais | en |
| dc.contributor.author | Perry Wasdin | en |
| dc.contributor.author | E et al | en |
| dc.contributor.author | Penelope Moore | en |
| dc.date.accessioned | 2026-02-24T19:35:45Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 0022-538X | en |
| dc.identifier.uri | https://hdl.handle.net/10539/48300 | |
| dc.journal.title | Glycanreactive antibodies isolated from human HIV1 vaccine trial participants show broad pathogen crossreactivity | en |
| dc.journal.volume | 99 | en |
| dc.publisher | AMER SOC MICROBIOLOGY | en |
| dc.title | Glycanreactive antibodies isolated from human HIV1 vaccine trial participants show broad pathogen crossreactivity | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 4.85 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client